Subscribe To
PSYK / Elemental Advisors President Talks Investing in Psychedelics Through PSYK
PSYK News
By Zacks Investment Research
February 2, 2022
Diversify Your Portfolio With a New Psychedelic Drug ETF
A new thematic ETF providing exposure to the medicinal psychedelic drug industry, PSYK ETF, has just been launched. more_horizontal
By Zacks Investment Research
February 2, 2022
Diversify Your Portfolio With a New Psychedelic Drug ETF
A new thematic ETF providing exposure to the medicinal psychedelic drug industry, PSYK ETF, has just been launched. more_horizontal
By Zacks Investment Research
February 2, 2022
Diversify Your Portfolio With a New Psychedelic Drug ETF
A new thematic ETF providing exposure to the medicinal psychedelic drug industry, PSYK ETF, has just been launched. more_horizontal
By Benzinga
February 2, 2022
New Psychedelics ETF Launches On NYSE Arca
Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to addr more_horizontal
By Benzinga
February 2, 2022
New Psychedelics ETF Launches On NYSE Arca
Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to addr more_horizontal
By Benzinga
February 2, 2022
New Psychedelics ETF Launches On NYSE Arca
Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to addr more_horizontal
By ETFcom
February 2, 2022
3rd Psychedelics ETF Launches
First-time issuer Elemental Advisors is the latest to create an ETF for the burgeoning industry. more_horizontal
By ETFcom
February 2, 2022
3rd Psychedelics ETF Launches
First-time issuer Elemental Advisors is the latest to create an ETF for the burgeoning industry. more_horizontal